Insider Transactions in Q1 2022 at T2 Biosystems, Inc. (TTOO)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2022
|
Michael Terrence Gibbs General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
8,790
-5.31%
|
$0
$0.44 P/Share
|
|
Mar 24
2022
|
Michael Terrence Gibbs General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+9.15%
|
-
|
|
Mar 14
2022
|
Alec Barclay Chief Operations Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,428
-6.33%
|
$0
$0.36 P/Share
|
|
Mar 14
2022
|
Alec Barclay Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,666
+10.72%
|
-
|
|
Feb 24
2022
|
John J Sperzel Iii |
SELL
Payment of exercise price or tax liability
|
Direct |
141,560
-42.47%
|
$0
$0.45 P/Share
|
|
Feb 24
2022
|
John J Sperzel Iii |
BUY
Exercise of conversion of derivative security
|
Direct |
333,333
+50.0%
|
-
|
|
Feb 24
2022
|
Michael Terrence Gibbs General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
76,867
-35.65%
|
$0
$0.45 P/Share
|
|
Feb 24
2022
|
Michael Terrence Gibbs General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
145,719
+40.33%
|
-
|
|
Feb 24
2022
|
John M Sprague Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
55,008
-28.77%
|
$0
$0.45 P/Share
|
|
Feb 24
2022
|
John M Sprague Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
145,719
+43.25%
|
-
|
|
Feb 21
2022
|
Michael Terrence Gibbs General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
5,275
-7.01%
|
$0
$0.47 P/Share
|
|
Feb 21
2022
|
Michael Terrence Gibbs General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+11.74%
|
-
|
|
Feb 21
2022
|
John M Sprague Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,775
-7.66%
|
$0
$0.47 P/Share
|
|
Feb 21
2022
|
John M Sprague Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+15.29%
|
-
|
|
Jan 06
2022
|
Aparna Ahuja Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
61,988
-36.55%
|
$0
$0.48 P/Share
|
|
Jan 05
2022
|
Aparna Ahuja Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
153,664
+47.54%
|
-
|
|
Jan 01
2022
|
David B Elsbree |
BUY
Exercise of conversion of derivative security
|
Direct |
32,258
+13.71%
|
-
|
|
Jan 01
2022
|
Thierry Bernard |
BUY
Exercise of conversion of derivative security
|
Direct |
32,258
+36.97%
|
-
|
|
Jan 01
2022
|
Seymour Liebman |
BUY
Exercise of conversion of derivative security
|
Direct |
32,258
+16.61%
|
-
|
|
Jan 01
2022
|
Ninfa Saunders |
BUY
Exercise of conversion of derivative security
|
Direct |
32,258
+36.97%
|
-
|
|
Jan 01
2022
|
Robin Toft |
BUY
Exercise of conversion of derivative security
|
Direct |
32,258
+36.97%
|
-
|